key: cord-0816243-4kd1xmel authors: Wang, F.; Pervaiz, U.; Tian, H.; Gahdary, M. O. A. O. A.; Hamid, M. A. M.; Wang, D. title: A Novel Primer Probe Set for Detection of SARS-CoV-2 by Sensitive Droplet Digital PCR date: 2020-11-04 journal: nan DOI: 10.1101/2020.11.03.20224972 sha: 31892678fcf0b01cd50cda25dd1ff0949f0faa79 doc_id: 816243 cord_uid: 4kd1xmel Background: The current increase in the spread of (SARS-CoV-2) critically needs a multitarget diagnostic assays to promote analytical sensitivity to facilitate the public health actions. Objective: The aim of this study was to develop a new primer-probe set targeting N gene of SARS-CoV-2 to improve the sensitivity for detection of COVID-19 Corona Virus Disease 2019 in multiplex rRT-PCR (Reversetranscript Realtime PCR) and ddPCR (Droplet Digital PCR). Results: We designed primers/probes set N(LZU3) targeting the N gene of 2019-nCov and proved its sensitivity in both rRT-PCR and ddPCR. When the quantity of template was 105 copies/reaction, the mean Ct value of N(LZU3) was 32.563, the detection rate was 91.7%. If the quantity of template was 52.5 copies/reaction, the mean Ct value of N(LZU3) was 33.835, and the detection rate was 83.3%, which were similar with that of N(CDC) and N(USA). The calculated lower limit of detection (LOD) of the new primer-probe set N(LZU3) used in rRT-PCR was 118 copies/reaction. We also did one-step ddPCR for detection the same serial dilution of RNA template. It shows good linearity for primer/probe sets N(LZU3). The calculated lower limit of detection (LOD) of N(LZU3) was 22.4 copies/reaction, which was 1.12 copies/ul. Conclusion: The novel primer-probe set(LZU3) targeting N gene of SARS-CoV-2 could be both used in rRT-PCR and ddPCR with better sensitivity, furthermore, ddPCR method had higer sensitivity than rRT-PCR, hence it could significantly improve SARS-CoV-2 detection efficiency in low virus load and asymptomatic infection. in rRT-PCR and ddPCR. This material was purchased from National Institute of Metrology of China (Beijing, China) . This reference material was obtained by in vitro 124 transcription of key characteristic genes of SARS-CoV-2, including the nucleoprotein 125 N gene (full length), the envelope protein E gene (full length) , and the open reading 126 frame1ab (ORF1ab) gene fragment (genomic position: 13201-15600, GenBank 127 No.NC_045512). In the material, the copy number of ORF1ab gene was about 9.00◊ 128 10 5 copies/µl, and the copy number of N gene was about 7.00×10 5 copies/µl. used the primers and probes used in previous research [21] . For targeting N gene, we 133 used 5 sets of primers/probes, N(CDC) and N(USA) were referred from previous 134 research (Laboratory testing for 2019-nCoV in humans) whereas N(LZU1), N(LZU2) 135 and N(LZU3) were designed by ourselves. The sequences are described in Table 1 . 136 Primers and probes were purchased from The Beijing Genomics Institute (Beijing, 137 China). All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi. org/10.1101 org/10. /2020 3.1 One-step rRT-PCR reagents and probe chemistries 189 Simplex rRT-PCR with different set of primers/probe was performed using a synthetic 190 standard RNA transcript with about 90000 copies/µl for ORF1ab and 70000 copies/µl 191 for N gene as the rRT-PCR template. Each experiment was performed in duplicate. We compared the amplification efficiency and the average Ct values for target Table 2 . The standard curves for each primer/probe set were 206 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10. 1101 shown in fig1. Comparing with the N(CDC) and N(USA1), N(LZU3) has the similar 207 Ct value and detection rate in the lower concentration of template, and the slope, 208 Y-intercept, R 2 of N(LZU3) were −3.228, 38.735, and 0.989, respectively (fig 2) . The 209 calculated PCR efficiency by machine was 104.093. The detection rate was 100% up 210 to 105 copies/reaction. The calculated lower limit of detection (LOD) with 95% 211 detection probability was 118 copies/reaction, which is the almost same as that of N 212 (CDC) (121 copies/reaction) and N (USA1) (119 copies/reaction), suggesting that the 213 prime/probe for N(LZU3) might be another potential primer/probe testing method for 214 target gene N of SARS-CoV-2. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in primes/probe sets (table 2) . Therefore, the ddPCR is more sensitive for samples with a 244 low level quantity of samples. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20224972 doi: medRxiv preprint We developed a new primer/probe set N (LZU3) for targeting N gene of SARS-CoV-2 251 for molecular diagnosis of COVID-19 in both rRT-PCR and ddPCR. The sensitivity 252 and specificity of rRT-PCR is affected by various factors, such as the nucleic acid 253 extraction method, the one-step rRT-PCR reagent, and the primer/probe sets. Optimizing protocols are required before using this methodology in diagnostic 255 laboratories [19] . There are more asymptomatic infection and mild symptomatic 256 infection in which the virus quantity might be very low, multiplex ddPCR might be 257 much more useful for detecting asymptomatic infection. We designed three primers/probes sets targeting the N gene of SARS-CoV-2. We also demonstrated that ddPCR had better sensitivity with lower LOD than 276 rRT-PCR. We chose different primer/probe sets N (CDC), N (USA) and N (LZU3) for 277 rRT-PCR, we found that the detection efficiency for low quantity of RNA template 278 (lower than 52.5 copies/reaction) were limited (lower than 85%). The LOD with 95% 279 detection probability for rRT-PCR was above 100 copies/reaction, which is 33.3 280 copies/ul. In this scenario we used one-step ddPCR to detect the same serial dilution 281 of RNA template. The LOD with 95% detection probability for ddPCR was about 20 282 copies/reaction, which is about 1 copy/ul, which was 5 times lower than rRT-PCR 283 These results confirmed that the ddPCR is more sensitive for low level quantity of 284 sample which is similar to previously reported results. [22, 23] . Moreover, the Biorad RNA Mini kit was also 625 cp/mL for N1 and N2, which were similar to our results. In order to improve the detection sensitivity and specificity of SARS-CoV-2, at least 291 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20224972 doi: medRxiv preprint two pairs of primer/probe sets were recommended for multiplex rRT-PCR or ddPCR. Our research demonstrated a pair of new primer/probe set for targeting N gene of 293 SARS-CoV-2, which would be provide a complementary for multiplex detection of 294 SARS-CoV-2. Comparing with the suggested methods (rRT-qPCR. next generation sequencing 297 (NGS), and immunological detection of IgM and IgG) for detection of SARS-CoV-2, 298 ddPCR had several advantages. First of all, nucleic acid detecting is the most direct 299 way to demonstrate the presence of the virus. Secondly, ddPCR may be more proper 300 in which nucleic acid detection is the most direct way to demonstrate the presence of 301 the virus [24] , it could achieve absolute quantification of SARS-CoV-2 without the 302 standard curve [24] . Thirdly, through detection within portioned droplets, ddPCR is 303 much more sensitive [25] and accurate [26] in portioned droplets detection, which is 304 might be a strong tool for the detection of very low viral load in mild symptomatic 305 and asymptomatic infection, it is also suitable for monitoring the change of the viral 306 load in the convalescent patients [27] . Fifthly, ddPCR has a good tolerance for PCR 307 inhibitory substances that might exist in the sample and reaction, therefore improve 308 the detecting efficiency [28] . An additional advantage of ddPCR is that it can provide 309 high concordance between sites, runs and operators [26, 29, 30] . However, it is not The only limitation of the assay is the lack of clinical samples which required 315 biosafety level 3 laboratory, however in future with the building of P3 facility, we will 316 continue our work on ddPCR detection of SARS-CoV-2. Conclusion 319 We developed another potential primer/probe set targeting N gene for the detection of 320 SARS-CoV-2, it could be used in both rRT-PCR and ddPCR. It can be combined with perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi. org/10.1101 org/10. /2020 Declaration of interests 335 Fang Wang, Umar Pervaiz and Hongwei Tian contributed equally to this work. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20224972 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20224972 doi: medRxiv preprint perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted November 4, 2020. ; https://doi.org/10.1101/2020.11.03.20224972 doi: medRxiv preprint Table1 Primers and probes used in rRT-PCR and ddPCR Name Sequence ( Brief Review on COVID-19: The 2020 Pandemic Caused by 342 SARS-CoV-2 The genetic sequence, origin, and 344 diagnosis of SARS-CoV-2. European journal of clinical microbiology & infectious 345 diseases : official publication of the European Society of Clinical Microbiology 2020 World Health Organization declares global emergency: A review of the 2019 novel 348 coronavirus (COVID-19) Clinical Characteristics 351 and Differential Clinical Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Diagnosing COVID-19: The Disease and 355 Tools for Detection Evaluation of a quantitative 357 in Canadian laboratories Improved Molecular Diagnosis of COVID-19 by the Novel Highly Sensitive and Specific COVID-19 Transcription-PCR Assay Validated In Vitro and with Clinical Specimens A new coronavirus 387 associated with human respiratory disease in China Comparative Performance of SARS-CoV-2 Detection 391 Assays Using Seven Different Primer-Probe Sets and One Assay Kit Journal of clinical virology : the official 396 publication of the Pan American Society for Clinical Virology Development of in vitro transcribed RNA as positive control for laboratory diagnosis of 399 SARS-CoV-2 in India Highly sensitive detection of SARS-CoV-2 RNA by multiplex 403 rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories. Clinica chimica 404 acta Limits of 406 Detection of Six Approved RT-PCR Kits for the Novel SARS-coronavirus-2 407 (SARS-CoV-2) Detection of 2019 novel coronavirus (2019-nCoV) 410 by real-time RT-PCR. Euro surveillance : bulletin Europeen sur les maladies 411 transmissibles Lan: ddPCR: a more sensitive and accurate tool for SARS-CoV-2 detection in low viral 416 load specimens Xiang Fang: Highly accurate and sensitive diagnostic detection of 420 SARS-CoV-2 by digital PCR Material for RT-PCR Detection of Middle East Respiratory Syndrome Coronavirus and 423